CEDAR Clinical Trials
Cancer early detection saves lives
At the OHSU Knight Cancer Institute, we envision a world freed from the burden of cancer. Our mission at the Cancer Early Detection Advanced Research Center, or CEDAR, is to detect and stop lethal cancers at the earliest stage. Why? Because early detection saves lives.
Identifying new ways to detect cancer at its earliest stages
Our team works on several multi-cancer early detection tests (MCEDs), such as the Pathfinder 2 study, which are tests that can screen for cancer in blood. We are researchers, administrators, phlebotomists and medical professional all working together to provide the most cutting-edge studies to our community. All share one common goal: To detect and eliminate cancers early.
Participation is free, easy and impactful
Taking part in research studies is an easy way to help identify cancer earlier, leading to better treatment outcomes and survival rates. You have a unique opportunity to both contribute to and benefit from advanced cancer research. Participation is free of charge, and often there is financial compensation involved for your time. It is also completely confidential, and often consists of only a medical history and one blood draw.
Who can take part?
We are looking for participants over the age of 45 in the following categories:
- Healthy patients without cancer in the last 3 years
- Patients with cancer who have not yet been treated for their cancer
Interested in participating?
If you are interested in learning more or participating, contact our team:
Help improve cancer early detection
Hear from a study participant
Tami Beaty is no stranger to cancer. She’s lost people she cared a lot about to cancer. In 2017, Tami discovered her own cancer after finding a lump in her breast while crossing her arms.